Hero banner

Pharmaceuticals 2024 - Recent Advances in Pharmaceutical Sciences Towards a Healthy Life

The 20th Anniversary

27 - 29 November 2024
Barcelona, Spain
Event Announcement

Join us for the 2nd Edition

Building on the success of our previous event, we are excited to announce that the The 2nd International Conference on Pharmaceuticals and New Trends in Drug Discovery (ICOPharm-2) will be held in Lisbon, Portugal on 11-14 May 2027.

The journey continues—join us for the ICOPharm-2!


Welcome from
the chairs
Welcome to Pharmaceuticals 2024, celebrating Pharmaceuticals' 20th anniversary! This meeting will showcase the art of discovering new molecules, their physical properties, and their modes of action in the search for molecular entities that can improve human health and quality of life.

Covering the newest technologies and the research areas of medicinal chemistry, natural products, organic synthesis, radiopharmaceuticals, pharmacology, toxicology, and biomolecular and glycosciences, among others, the meeting will bring together experts to present their latest findings on combatting infection, inflammation, pain, and neurodegeneration, to cite some of the relevant topics that will be discussed.

In this meeting, we encourage participation from all areas of pharmaceutical research to highlight recent advances in the field of applied chemistry in the search for novel solutions for the world‘s pharmaceutical needs. We will finally meet in person and will have the opportunity to bring together the younger generation, the experts, and companies to plan science and technology for the future. A roundtable will be organized to start and facilitate further discussions.

We are very pleased to announce that a ceremony is also planned to honor Prof. Jean Jacques Vanden Eynde, former Editor in Chief of Pharmaceuticals (2015-2022), in recognition of his years-long dedication to Pharmaceuticals.

Please receive our warmest invitation to join us in Barcelona from the 27th to the 29th of November this year!

Prof. Dr. Amelia Rauter, Dr. Alfredo Berzal Herranz, and Prof. Dr. Mary Jane Meegan
Pharmaceuticals 2024 Chairs

Follow the conversation on Twitter/X with #Pharmaceuticals2024


Conference Secretariat

Dr. Ana Sanchis
Ms. Raquel Sellés
Dr. Elena González
Email: pharmaceuticals2024@mdpi.com



Meet Our Chairs

Explore more chairs
Prof. Dr. Amelia Pilar Rauter

Departamento de Química e Bioquímica (DQB) e Centro de Química Estrutural (CQE), Institute of Molecular Sciences, Faculdade de Ciências, Universidade de Lisboa, Portugal;Prof. Dr. Amélia Pilar Rauter, a full professor, was the founder of the Portuguese Society of Chemistry Carbohydrate Chemistry Group in 1992, and the founder (2001) and leader of the CQB Carbohydrate Chemistry Group—FCUL, a center of excellence of the ESF network Euroglycoforum (2009–2014), and Executive of its Interest Group Glycochemistry. Presently, she is the leader of the CQE Carbohydrate Chemistry Group. Her scientific interests are mainly within the area of organic and biomolecular chemistry. They cover the design and synthesis of new leads based on carbohydrate structures with new mechanisms of action, as well as the isolation and structure elucidation of active principles from plants/marine resources. This research led to the discovery of lead molecules for diabetes, degenerative diseases (Alzheimer´s and Prion diseases, cancer), and infection. Her research falls within the global objective of developing creative and sustainable chemistry for better health.

Dr. Alfredo Berzal Herranz

Department of Molecular Biology, Instituto de Parasitología y Biomedicina López-Neyra (IPBLN) CSIC, Spain;Alfredo Berzal-Herranz received his PhD in Molecular Biology from the Autonoma University of Madrid (1990). After a short stay in the Department of Microbiology, at the Uppsala University (Sweden), he moved to the Department of Microbiology, College of Medicine, University of Vermont (USA), as Postdoctoral Researcher. In 1993 he returned to Granada, Spain, joining the Instituto de Parasitologí¬a y Biomedicina López-Neyra (IPBLN) belonging to the Spanish National Research Council (CSIC), where he established his own research group and Chair the Department of Molecular Biology. Since April 1997 to November 2005, he was the Deputy Director of the IPBLN-CSIC and Director since November 2005 to March 2014. He has authored over 90 research articles and book chapters and edited 10 special research issues. He serves or has served as Editorial Board Member of more than 15 research journals. His group is currently interested in understanding the structure/function relationship of viral RNA genomes. Pursuing the identification of the molecular mechanisms used by the RNA viruses to store all necessary genetic information and studying the potential use of genomic structural RNA domains as potential antiviral targets. Further, his group is interested in the design and characterization of antiviral RNA molecules.

Prof. Dr. Mary Jane Meegan

School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Ireland;Mary J Meegan completed her PhD degree in UCD under the direction of Professor Dervilla Donnelly in the area of natural product chemistry and subsequently carried out postdoctoral research at the University Chemical Laboratory, Cambridge University in the research group of Professor Alan Battersby in the area of porphyrin synthesis and biosynthesis. Following further research periods at University College Dubin and CNRS Gif-sur-Yvette, she was appointed as lecturer in Pharmaceutical Chemistry at the School of Pharmacy and Pharmaceutical Sciences in Trinity College Dublin. She has research experience in the School of Pharmacy and and Pharmaceutical Sciences, Trinity College in the general area of pharmaceutical and medicinal chemistry, with over 100 peer-reviewed scientific papers covering topics such as design and synthesis of anticancer drugs, drug impurity profiling, synthetic methods for library design and in vitro screening. She has extensive experience in scientific and technical management having led an active research group, has acted as Head of the Department of Pharmaceutical Chemistry and as subject area head of Pharmaceutical Chemistry at the School of Pharmacy. Research collaborations have been established within Trinity College with Dr. Niamh O'Boyle (School of Pharmacy and Pharmaceutical Sciences), Dr D Zisterer, Dr D Fayne in the School of Biochemistry and Immunology and also with many European research centres. She is a member of several International Scientific Societies.

Important Dates

2 Jul

2024 (23:59 AoE)

6 Sep

2024 (23:59 AoE)

4 Oct

2024 (23:59 AoE)

9 Oct

2024 (23:59 AoE)

20 Nov

2024 (23:59 AoE)

20 Nov

2024 (23:59 AoE)

20 Nov

2024 (23:59 AoE)

Meet Our Speakers

Explore more speakers
Prof. Dr. Jesús Jiménez-Barbero

CIC bioGUNE, Bizkaia Technology Park, Spain;Ikerbasque, Basque Foundation for Science, Spain;Jesús Jiménez-Barbero is Ikerbasque Research Professor and Scientific Director of CIC bioGUNE since 2014. He received his PhD in 1987. He later spent pre- and post-doc stages (1988-1992) at CERMAV-CNRS; Univ Zurich; National Institute for Medical Research, and Carnegie Mellon. Before moving to CIC bioGUNE where he has led its recognition as Severo Ochoa Center of Excellence in 2017 and 2022, he was CSIC Research Professor at CIB-CSIC (2002-14). Previously, he was CSIC tenured (1992-96) and senior scientist (1996-2002), and Visiting Professor at École Normale Supérieure (2004), Sorbonne (2009), Milano Bicocca (2009-12). Now at the University Basque Country since 2016.

Prof. Dr. Peter Seeberger

Max Planck Institute of Colloids and Interfaces, Director. Department of Biomolecular Systems;Free University Berlin, Professor. Institute of Chemistry and Biochemistry;Peter H. Seeberger, a chemist, was a tenured professor at MIT and ETH Zurich before becoming director at the Max-Planck Institute in Potsdam in 2009. Since 2021, he is a Vice President of the German Research Foundation (DFG) and since 2023 the Founding Director of the Center for the Transformation of Chemistry (CTC) that received initial funding of €1.25 billion. His research spanning topics from engineering to immunology has been documented in >670 journal articles and >60 patents was recognized with >40 international awards. Peter Seeberger supports open access publishing as the Editor-in-Chief of the Beilstein Journal of Organic Chemistry. He is a co-founder of the Tesfa-Ilg Foundation that works in Ethiopia and nine successful companies.

Prof. Dr. Tanja M. Wrodnigg

Institute of Chemistry and Technology of Biobased Systems, Graz University of Technology, Austria;Tanja M. Wrodnigg received her Ph.D. in 1999 at Graz University of Technology in Austria in the field of Glycochemistry supervised by Arnold E. Stütz. From 2001 – 2003 she joined Prof. Stephen Withers at UBS in Vancouver University of British Columbis where she worked on the synthesis for glycosynthases and their biological investigation. Back in Austria she started her independent career at the Institute of Organic Chemistry and in 2008 she received her Habilitation in Organic Chemistry, Glycochemistry. In 2020 Tanja was appointed as full professor for Glycochemistry at Graz University of Technology and established the Institute for Chemistry and Technology of Biobased Systems at TU Graz. Research interest is the design of efficient and concise synthetic approach of biological active glycomimetics, carbohydrate processing enzyme inhibitors, probes for activity based protein profiling, lectin ligands, biological active materials, method development for polysaccharides modification.

Sponsors and Partners

Organizer


MDPIPharmaceuticals

Partnering society


Spanish Society Of Medicinal Chemistry (SEQT)Spanish Society For Biochemistry And Molecular Biology (SEBBM)

Media partner


PharmaceuticsMarine DrugsBiomedicinesMacromolDrugs and Drug CandidatesPharmacoepidemiologyChemistryBiomoleculesScientia PharmaceuticaMedicines
Pharmaceuticals 2024 - Thank you for your participation!

For more photos and moments of the conference please visit our Gallery!

Pharmaceuticals 20th Anniversary
The year 2024 marks the 20th anniversary of Pharmaceuticals (ISSN: 1424-8247), a peer-reviewed open access journal on medicinal chemistry and related drug sciences, published monthly online by MDPI. To honor that, we are reflecting on our past accomplishments and embarking on an exciting new chapter. This celebration is also one of the reasons to organize the conference Pharmaceuticals 2024. With an Impact Factor of 4.3 and a CiteScore of 6.1, the journal is covered in Scopus, SCIE (Web of Science), PubMed, PMC, Embase, CAPlus/SciFinder, and other databases. The journal has published more than 6000 papers from more than 37,000 authors. More than 10,000 reviewers have reviewed the journal at least once.
We invite you to join us in celebrating this milestone for the journal by exploring the shared experiences of the chairs, honorary guest and committee members of the conference in the video below!

20th Anniversary of Pharmaceuticals Video

Conference Dinner

We are excited to announce that the Conference Dinner will be held at the prestigious Gallery Hotel, located in the heart of Barcelona. Enjoy a delightful evening in a vibrant setting next to iconic landmarks such as La Pedrera, Passeig de Gràcia, Casa Batlló, and Plaça Catalunya.

Time: 28 November 2024, 20.30h
Location: Gallery Hotel. C/ del Rosselló, 249, 08008 Barcelona
Menu: 60€
Main course options: meat, fish or vegetarian

Please let us know in your registration your main course preference and any allergies or relevant dietary restrictions.

Join us for an unforgettable dining experience in one of Barcelona's most renowned locations. We look forward to seeing you there!

Poster Sessions

The posters have been divided into two groups and will be presented in one of the two poster sessions.

Poster Session A
Posters: A1 – A17
Wednesday, 27 November 2024 (15:30–17:00)

Posters should be set up on Wednesday morning and must be removed by 18:30 on the same day.

Poster Session B
Posters: B1 – B17
Thursday, 28 November 2024 (12:30–14:30)

Posters should be set up on Thursday morning and must be removed by 18:30 on the same day.

Each presenter will be provided with a vertical poster board. Note that the maximum poster size limited to A0:

- 84 x 120 cm / 33 x 47 in (width x height)

- in vertical orientation (portrait)

Please print your poster prior to the conference.

The session for each poster, along with the poster numbers, titles, and presenting author, can be found below. Please contact us if the poster presenter's name is incorrect in this list.

By clicking on the icon below, you can view and download the list of posters (updated 11.11.2024)

Pharmaceuticals2024

Powered by Sciforum
Disclaimer
Terms and ConditionsPrivacy PolicyAccessibility